Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

Presentation ESC 2025

AQUATIC: Assessment of Quitting versus Using Aspirin Therapy In patients with stabilized Coronary artery disease after stenting who require long-term oral anticoagulation

Presenter: Martine Gilard

August 30, 2025

Presentation

Antithrombotic Therapy and CV Outcomes After TAVR in A-fib Patients

August 20, 2019

Presentation EuroPCR 2017

Efficacy and Safety of LAA Closure with WATCHMAN in Patients with or without Contraindication to Oral Anticoagulation: 1-year FU of the EWOLUTION trial

Presenter: Lucas Boersma, Martin W. Bergmann

May 18, 2017

Presentation

6 Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism

Presenter: Francis Couturaud

July 10, 2015

Presentation

Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After DES Implantation

Presenter: K.A. Fiedler

April 22, 2015

Presentation Cardiovascular Interventions 2014

How to Manage Post PCI Antiplatelet Therapy in the Patient on Oral Anticoagulation

Presenter: David P. Faxon

October 23, 2014

Presentation

Use and Associated Risks of Concomitant Aspirin with Oral Anticoagulation in A-fib Patients

Presenter: B. A. Steinberg

July 24, 2013

Presentation

Oral Anticoagulation (OAC) and Antiplatelets inA-fib Patients After MI and PCI

Presenter: M. Lamberts

June 12, 2013

Presentation PCI Outcomes 2013

DAPT + Oral Anticoagulation: Indications and Risk Amelioration

Presenter: C. Michael Gibson

March 07, 2013

Advertisement

AQUATIC: Assessment of Quitting versus Using Aspirin Therapy In patients with stabilized Coronary artery disease after stenting who require long-term oral anticoagulation

Antithrombotic Therapy and CV Outcomes After TAVR in A-fib Patients

Efficacy and Safety of LAA Closure with WATCHMAN in Patients with or without Contraindication to Oral Anticoagulation: 1-year FU of the EWOLUTION trial

6 Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism

Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After DES Implantation

How to Manage Post PCI Antiplatelet Therapy in the Patient on Oral Anticoagulation

Use and Associated Risks of Concomitant Aspirin with Oral Anticoagulation in A-fib Patients

Oral Anticoagulation (OAC) and Antiplatelets inA-fib Patients After MI and PCI

DAPT + Oral Anticoagulation: Indications and Risk Amelioration

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content